Cite

HARVARD Citation

    Chang, A. et al. (2016). Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study. BMC nephrology. 17 (1), pp. 1-9. [Online]. 
  
Back to record